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INTRODUCTION
Members of the cytochromes P450 (P450s) gene superfamily have been intensely studied due to their ability to catalyze the metabolism of a broad array of xenobiotics and endogenous compounds (Kroetz and Zeldin, 2002; Nebert and Russell, 2002; Nelson et al, 1996) . Arachidonic acid (AA) is a polyunsaturated fatty acid present in mammalian cell membranes that can undergo NADH-dependent oxidation by certain P450s to generate bioactive metabolites such as epoxyeicosatrienoic acids (EETs) (Capdevila et al, 2000; Kroetz and Zeldin, 2002; Nebert and Russell, 2002) . EETs have a wide range of physiological functions including anti-inflammatory (Node et al, 1999) , cardioprotective (Seubert et al, 2004; Seubert et al, 2006) , fibrinolytic (Node et al, 2001 ), angiogenic (Wang et al, 2005) and vasodilatory (Campbell et al, 1996; Larsen et al, 2006) 
effects both in vitro and in vivo.
One of the largest subfamilies of the P450s is the CYP2C subfamily. Many species contain multiple CYP2C subfamily members; rats have nine Cyp2c genes, while humans have four CYP2C genes (Nelson et al, 1996) . The mouse Cyp2c subfamily is made up of 19 subfamily members, 4 of which are pseudogenes with no open reading frame. Eighteen of the nineteen genes are located within a ~1.5 Mb cluster on mouse chromosome 19. The nineteenth gene, Cyp2c44, is located ~3.8 Mb away from the colon (Wang et al, 2004) while the Cyp2c44 epoxygenase has been shown to be expressed in liver and the renal collecting duct (Capdevila et al, 2014; DeLozier et al, 2004) . The remaining mouse Cyp2c cDNAs (Cyp2c65, Cyp2c66, Cyp2c67, Cyp2c68, Cyp2c69 and Cyp2c70) were not previously cloned and no analysis of their tissue distribution at the RNA level has been reported.
Although non-quantitative RT-PCR detects whether a particular transcript is present or not, it doesn't allow for the quantification of the transcript level. Quantitative polymerase chain reaction (qPCR) monitors the amplification of targeted sequences in real time, which allows accurate measurement of gene expression. For all qPCR reactions cDNA-specific primer pairs are used to amplify a target sequence from the transcript of interest. The SYBR Green qPCR method uses a double-stranded DNAbinding dye as the reporter (Ponchel et al, 2003) . TaqMan or Quantifast qPCR methods rely on endonuclease activity cleaving a fluorophore from a transcript-specific probe containing a fluorescent quencher (Heid et al, 1996) . Of the two methods, Taqman primer/probe assays have the advantage of increased selectivity due to their targetspecific fluorescent probe. Unfortunately, researchers cannot confirm whether the measured fluorescence of primer/probe assays is due to a single target amplicon as opposed to multiple off-target transcripts. This becomes especially important when quantifying members of a highly conserved subfamily of genes such as the mouse Cyp2cs, which have 53-98% cDNA sequence identity (Table 1) . DNA-binding assays such as SYBR Green might also fail to distinguish between highly related transcripts; however, they allow for performance of an end-point melting curve assay that can determine whether the observed fluorescence is due to a single amplicon or multiple DMD #75697 unintended amplicons. Although the SYBR Green melting curve assay will not differentiate multiple amplicons of the same melting temperature, the end-point assay does provide a level of confirmation that is not possible with primer/probe qPCR assays.
In this study SYBR Green primer sets were developed for use in qPCR assays based on published and cloned cDNA sequences of members of the mouse Cyp2c subfamily. These primer sets were compared with the commercially available mouse Cyp2c TaqMan primer/probe assays. Ten TaqMan primer/probe assays were shown to be specific for their intended transcript. All fifteen of the SYBR Green primer sets were found to be specific for their intended transcript. Similar tissues distribution profiles were obtained using both qPCR methods. cDNA Reverse Transcription Kit from Life Technologies was used according to the manufacturer's protocol to produce cDNA from the DNase I treated RNA. The final concentration of the cDNA archives was 10 ng/μl, which was diluted to a working concentration of 1 ng/μl with RNase-free water.
MATERIALS AND METHODS
Reagents and
Cloning of cDNAs for Cyp2c Subfamily Members. The cDNAs for Cyp2c65.
Cyp2c67, Cyp2c68 and Cyp2c69 were identified by sequence analysis using the National Center for Biotechnology Information (NCBI) database's Basic Local Alignment Search Tool (BLAST) and the Lasergene DNAStar v12 package (Madison, WI). Primer pairs were designed to amplify the coding regions of Cyp2c67, Cyp2c68 and Cyp2c69 cDNAs (Table 2) . Primers for the Cyp2c65 cDNA included the 3' UTR sequence. Briefly, 60 ηg of stomach or liver cDNA archives (as described above) were amplified using Cyp2c69 amplicons. The PCR products were then gel isolated using a Qiagen kit. An A-overhang was added using New England BioLabs' Taq DNA polymerase and the cDNA was cloned into the pRC2.1-TOPO vector from Life Technologies. Positive clones were identified using blue-white selection. Sequence fidelity was verified by DNA sequencing (GeneWiz, Inc.; Research Triangle Park, NC).
TaqMan qPCR. Life Technologies' TaqMan primer/probe assays for the mouse Cyp2jc subfamily members are listed in Table 3 . For all qPCR reactions, 0.5 μl of the 
SYBR Green qPCR.
Specific primer sets of oligonucleotides were designed, spanning exon-exon boundaries when possible, for the protein coding members of the mouse Cyp2c subfamily (Table 4 ). Due to high sequence homology with other paralogs, the primer set for Cyp2c65 was designed in the 3' UTR. Additional mouse Cyp2c primer sets that were used had previously been published for use in non-quantitative RT-PCR (Luo et al, 1998; Wang et al, 2004) . All SYBR Green qPCR assays were run in 10 μl qPCR Analysis. Data generated from qPCR was analyzed using the 2 -∆∆C T method (Livak and Schmittgen, 2001 ). All graphs were generated using the GraphPad Prism 6.0C program (GraphPad Software, San Diego, CA). Mouse tissue expression values were normalized to glyceraldehyde 3-phosphate dehydrogenase (Gapdh) expression values. To confirm specificity against cloned cDNAs, SYBR Green qPCR assay values were normalized to β-lactamase (ampicillin resistance) from the cDNA vector. Outliers were determined using the Grubbs Outlier test (Grubbs, 1950) .
Significance for sex differences in various tissues was determined using the Student's ttest. No statistical comparisons were performed between tissues. The cDNA and tissue heat maps were generated using the Microsoft Excel program (Microsoft, Redmond, WA). Relative tissue expression was normalized to Gapdh; ∆CT values (Cyp2c -Gapdh) are reported in the heat map (Fig. 2) .
RESULTS
Specificity of the Mouse Cyp2c TaqMan primer/probes and SYBR Green
Primer Sets. The mouse Cyp2c subfamily cDNAs, except for Cyp2c65, Cyp2c67, Cyp2c68 and Cyp2c69, were previously cloned in collaboration with Dr. Joyce
Goldstein's laboratory (DeLozier et al, 2004; Luo et al, 1998; Wang et al, 2004) . Each
This article has not been copyedited and formatted. The final version may differ from this version. Ten of the eleven commercially available gene-specific mouse Cyp2c TaqMan primer/probe assays (Table 3 ) preferentially detected their target cDNAs (Fig. 1A) . Only the Cyp2c29 probe failed to detect its respective cDNA and had cross-reactivity with the Cyp2c50, Cyp2c54, Cyp2c55 and Cyp2c66 cDNAs. The TaqMan Cyp2c29 probe amplifies an 89 bp amplicon completely located within terminal exon 9. It may be that this amplicon spans both coding and non-coding sequence of exon 9. If this is the case, then the assay may be unable to detect the Cyp2c29 ORF cloned which lacks the complete 3' UTR. The Cyp2c38 TaqMan primer/probe recognized the Cyp2c38 cDNA but also had some (30-35%) cross-reactivity to the Cyp2c66 isoform (Supplemental Fig.   3A ). Both the Cyp2c44 and the Cyp2c54 TaqMan primer/probes had low but detectable cross-reactivity to the Cyp2c39 and Cyp2c29 transcripts respectively (Fig. 1A) . Four
TaqMan primer/probe assays (Table 3) were all advertised as having cross-reactivity between the Cyp2c40, Cyp2c67, Cyp2c68 and Cyp2c69 subfamily members. Results confirmed cross-reactivity of all four TaqMan primer/probe assays for these four mouse Cyp2c isoforms (Fig. 1A, Supplemental Figs. 7, 16, 17, and 19) .
The fifteen mouse Cyp2c SYBR Green primer sets were specific for their intended ORF targets (Fig. 1B) . The Cyp2c29 primer set had low but detectable crossreactivity to the Cyp2c38 and Cyp2c50 cDNAs ( 
1D). Detection of Cyp2c29
expression in liver is consistent with published non-quantitative RT-PCR data, although no difference in expression between the sexes was previously reported (Luo et al, 1998) . Cyp2c29 was also reported to be expressed in the intestines by non-quantitative RT-PCR (Luo et al, 1998) , which is consistent with the expression of Cyp2c29 in duodenum by the SYBR Green primer set in the current work. Cyp2c29 was also detected in jejunum by the SYBR Green primers at low levels; however, the expression of Cyp2c29 in brain, kidney, lung and heart by the non-quantitative RT-PCR method (Luo et al, 1998) was not confirmed using the SYBR Green qPCR method. There is an approximate melting temperature of 82. 
1C). It is interesting to note that Cyp2c29
is the only isoform with higher expression in male liver than in female liver.
Previous non-quantitative RT-PCR experiments, which used only female mouse tissues, demonstrated liver-specific expression of Cyp2c37 (Luo et al, 1998) . Both qPCR methods also revealed Cyp2c37 expression was highest in liver, but with significantly greater expression in female liver than in male liver ( Prominent Cyp2c38 transcripts were found in both male and female livers with a significantly higher expression in female versus male liver using both qPCR methods ( 2C ). The expression detected in duodenum, jejunum, kidney, lymph node, skin, testis and uterus by the Cyp2c38 TaqMan primer/probe may be explained by its cross-reactivity to Cyp2c66, which is highly expressed in the gastrointestinal tract and testis ( Fig. 2 ; Supplemental Fig. 12 ). Nonquantitative RT-PCR, using only female mouse tissues, previously demonstrated the presence of the Cyp2c38 transcript in liver, brain, kidney, and intestine with much lower levels of expression in lung and heart (Luo et al, 1998) .
This article has not been copyedited and formatted. The final version may differ from this version. Published non-quantitative RT-PCR experiments using only female mouse tissues demonstrated Cyp2c39 expression specifically in liver (Luo et al, 1998) qPCR results from the Cyp2c39 TaqMan primer/probe and SYBR Green primer set confirmed highest expression in the liver, but also revealed higher Cyp2c39 expression in female liver than in male liver ( Fig. 2 ; Table 5 ; Supplemental Fig. 5 ). Cyp2c39 was also found at much lower but detectable levels in other tissues examined including aorta, kidney, large intestine, and lung with both qPCR methods. The dissociation curve for liver with the SYBR Green Cyp2c39 primer set revealed a single prominent peak with a melting temperature of 80.3°C (Supplemental Fig. 2D ).
For Cyp2c40, the highest expression using the SYBR Green primer set was in the liver. Cyp2c40 is more highly expressed in female liver compared to male liver ( brain and kidney with lower expression also present in lung and heart (Luo et al, 1998) .
There is no Cyp2c40-specific TaqMan primer/probe available. All four TaqMan primer/probes tested ( Expression levels for Cyp2c50 were approximately the same for both male and female liver using both qCPR methods. For the SYBR Green primer set, very low levels of Cyp2c50 transcript, (CT values of ~36), were detected in the remaining tissues tested.
The SYBR Green Cyp2c50 dissociation curves were examined and only liver gave a single dominant peak with a melting temperature of approximately 81.5°C
(Supplemental Fig. 2G ), which suggests that the low level of detection in other tissues
This article has not been copyedited and formatted. The final version may differ from this version. represents cross-reactivity with non-target transcripts. Previous non-quantitative RT-PCR methods detected the expression of Cyp2c50 in the liver and heart (Wang et al, 2004) . Heart expression of Cyp2c50 was not confirmed by either qPCR method used in this study.
Prominent Cyp2c54 expression was detected in male and female liver using both qPCR methods. Significantly higher expression was detected in female liver compared to male liver ( demonstrated that Cyp2c55 transcripts were present in all the tissues examined (liver, kidney, lung, heart, brain, spleen, colon, small intestine, stomach, testis, skeletal muscle, aorta, adrenal gland, prostate and ovary). Using both the TaqMan primer/probe and SYBR Green primer sets, Cyp2c55 was found to be most abundant in the large intestine with significantly higher expression in male versus female large intestine ( The Cyp2c65 SYBR Green primer set amplifies a region of the 3' UTR. The
Cyp2c65 SYBR Green dissociation curves gave a single prominent peak with an approximate melting temperature of 76.5°C for stomach, duodenum, ileum, jejunum, large intestine, testis and esophagus ( Fig. 3; Supplemental Fig. 2J ). To confirm specificity for Cyp2c65, the SYBR Green qPCR reactions for stomach, duodenum and large intestine were run on agarose gels. A single band was obtained for each, which was isolated using a Qiagen Gel Isolation Kit. The isolated bands were sequenced using the Cyp2c65 SYBR Green primers. For all three tissues tested the sequence matched the predicted Cyp2c65 sequence (Fig. 3B ). This strongly suggests that the SYBR Green Cyp2c65 primer set specifically detect only the Cyp2c65 transcript in these tissues. Cyp2c65 transcripts were detected in stomach, duodenum, and large intestine with much lower expression in jejunum, testis and esophagus by both qPCR methods ( Fig. 2 ; Table 5 ; Supplemental Fig. 11 ). There was significantly higher expression in female large intestine than male large intestine by both qPCR methods.
There was also significantly higher expression in male jejunum compared to female jejunum with the Cyp2c65 TaqMan primer/probe. This sex difference in the SYBR Prominent Cyp2c66 transcripts were detected in duodenum and jejunum, with significantly lower expression in large intestine and testis using both qPCR methods ( Fig. 2 ; Table 5 ; Supplemental Fig. 12 ). There was significantly higher expression in male jejunum than female jejunum. Conversely, there was significantly higher expression in female large intestine compared to male large intestine using both qPCR methods. A single dominant peak for duodenum and jejunum gave an approximate melting temperature of 79.0°C for the Cyp2c66 SYBR Green primer set (Supplemental Figure 2K ). Cyp2c66 expression has not previously been reported.
There were no previous non-quantitative RT-PCR studies found with mouse
Cyp2c67. We detected a prominent Cyp2c67 transcript in liver using the SYBR Green primer set with similar expression in both sexes ( Fig. 2 ; Table 5 ; Supplemental Fig.   13D ). There is no Cyp2c67-specific TaqMan primer/probe assay available (Fig. 1) . The
TaqMan primer/probe (Table 3 ) used for comparison with the Cyp2c67 SYBR Green primers also strongly recognizes the Cyp2c40, Cyp2c68 and Cyp2c69 transcripts (Supplemental Fig. 13A ). This cross-reactivity likely accounts for the higher expression observed in female liver in comparison to male liver since this sex difference is also seen using the Cyp2c40-, Cyp2c68-and Cyp2c69-specific SYBR Green primer sets ( Fig. 6D; Fig. 14D ; Fig. 15D ). A single prominent peak was observed using the SYBR Green primers with liver that had an approximate melting temperature of 77.5°C
(Supplemental Fig. 2L ).
The Cyp2c68 SYBR Green primer set detects the highest expression in liver with significantly greater expression in female liver versus male liver (Fig. 2. ; Table 5 ;
Supplemental Fig. 14) . Cyp2c68 transcripts were also detected in duodenum, ileum, jejunum, large intestine, stomach and kidney, which is confirmed by the dissociation curves. A single dominant peak for liver has an approximate melting temperature of 80.0°C (Supplemental Fig. 2M ). There was significantly higher expression of Cyp2c68 in female large intestine when compared to male large intestine. There is no specific Cyp2c68 TaqMan primer/probe available ( Fig. 1; Supplemental Fig. 14A ). The expression pattern seen with the TaqMan primer/probe used for comparison (Table 3) could be due to detection of Cyp2c40, Cyp2c67, and Cyp2c69, as well as Cyp2c68 since all four isoforms are recognized by this primer/probe assay. No non-quantitative RT-PCR experiments for Cyp2c68 expression were previously reported.
A prominent transcript is detected in liver using the Cyp2c69-specific SYBR Green primers ( Fig. 2 ; Table 5 ; Supplemental Fig. 15 ). There is significantly higher Cyp2c69 expression in female liver compared to male liver. The dissociation curves for the Cyp2c69 SYBR Green primer set reveals a single peak with a melting temperature of approximately 77.0°C (Supplemental Fig. 2N ). There is no specific TaqMan primer/probe assay for mouse Cyp2c69. The Cyp2c69 TaqMan primer/probe assay (Table 3) used also recognizes Cyp2c40, Cyp2c67 and Cyp2c68 (Supplemental Fig.   15A ). The expression pattern observed with this primer/probe could be due to reactivity with any of the other four isoforms (Fig. 1) . No non-quantitative RT-PCR experiments for mouse Cyp2c69 were available as a comparison.
Finally, both qPCR methods detected Cyp2c70 only in liver ( Fig. 2 ; Table 5 ; Supplemental Fig. 16 ). There were no expression differences between the sexes. The dissociation curves for liver gave a single dominant peak with an approximate melting 
DISCUSSION
The four human CYP2C isoforms (CYP2C8, CYP2C9, CYP2C18, and CYP2C19) account for 20% of hepatic P450s and are active in the metabolism of many widely used drugs (Goldstein and de Morais, 1994 ) and endogenous compounds (Daikh et al, 1994; Zeldin et al, 1995) . In comparison, the mouse Cyp2c subfamily is larger and more complex with fifteen subfamily members (Nelson et al, 1996; Wang et al, 2004) .
Mouse Cyp2c enzymes also metabolize both endogenous and exogenous compounds This cross-reactivity is not surprising due to the ~75% identity between the Cyp2c38 and Cyp2c66 cDNAs. The Cyp2c29 TaqMan primer/probe does not recognize it's intended cDNA, but this is most likely due to the probe partially targeting the 3' UTR that is absent from our cDNA. The remaining TaqMan primer/probes used for this study are not advertised as being specific for the Cyp2c40, Cyp2c67, Cyp2c68 and Cyp2c69 isoforms. These assays were included for comparison to the SYBR Green primer sets developed for these Cyp2c subfamily members.
The fifteen mouse Cyp2c SYBR Green primer sets are highly specific for their intended Cyp2c cDNA. These include the four isoforms (Cyp2c40, Cyp2c67, Cyp2c68
and Cyp2c69) for which there are no specific TaqMan primer/probes.
Tissue expression profiles of the mouse Cyp2c isoforms were generally similar using both qPCR methods. Of the fifteen mouse Cyp2c subfamily members, twelve were most highly expressed in liver. Mammalian P450s highly expressed in liver have important roles in the metabolism of certain drugs (Guengerich, 1992) . Human Cyp2cs are known to metabolize clinically relevant drugs such as tolbutamide, which is used for the management of type 2 diabetes (Veronese et al, 1991) , as well as anti-inflammatory drugs such as ibuprofen and acetylsalicylic acid (aspirin) (Leemann et al, 1993 (Jackson et al, 2004; Jackson et al, 2006; Konno et al, 2010 ). It will be important to test the remaining mouse Cyp2cs for their ability to metabolize drugs to better understand their physiological roles in the liver.
Six of the twelve mouse Cyp2c enzymes that are most highly expressed in the liver (Cyp2c37, Cyp2c38, Cyp2c39, Cyp2c40, Cyp2c54 and Cyp2c69) are found to have significantly higher expression in female liver when compared to male liver. There is only one isoform (Cyp2c29) that has significantly higher expression in male liver compared to female liver. It is well known that sex differences found in the metabolism of many pharmaceuticals are due, at least in part, to sex differences in expression of hepatic enzymes, including P450s (Waxman and Azaroff, 1992; Waxman and Holloway, 2009 ).. Identifying these sexually dimorphic mouse Cyp2c enzymes in liver may aid in understanding differences in drug potency observed in male versus female mice.
However, sexual dimorphism is much less pronounced in human models in comparison to rodent models (Lofgren et al, 2008; Tanaka, 1999) which must be taken into account when using the mouse as a model for human disease and drug metabolism.
Cytochrome P450 enzymes primarily expressed in the gastrointestinal tract may also play an important role in drug elimination as well as biotransformation of other exogenous and endogenous compounds (Kaminsky and Fasco, 1992; Paine et al, 2006; Wang et al, 2004 Cyp2c66 are highly expressed in the gastrointestinal tract with similar tissue expression profiles for each isoform. Previously Cyp2c40 was identified as the major Cyp2c isoform present in the intestine (Tsao et al, 2000) ; however, with more sensitive and paralogspecific qPCR methods, we identified other highly expressed Cyp2c isoforms in the intestinal tract and that Cyp2c40 is predominantly expressed in female liver.
Mouse models exist that have disruption of Cyp2c isoforms. Cyp2c44
-/-mice have hyperactive epithelial sodium channel (ENaC) activity in the kidney and are more susceptible to salt-induced hypertension than WT mice. The authors concluded that CYP2C44 normally generates EETs to suppress ENaC activity and limit sensitivity to high-salt diet (Capdevila et al, 2014) . Our data suggest that Cyp2c44 is the predominant Cyp2c expressed in the kidney. Another mouse model has the 14 Cyp2c gene cluster genetically disrupted with only the downstream Cyp2c44 locus intact. These mice are viable and healthy, though some animals exhibited liver inflammation. They also have significantly reduced metabolism of known CYP2C substrates such as tolbutamide (Scheer et al, 2012) . Together, these models will be important for elucidating the roles of mouse CYPC enzymes in cardiovascular physiology and xenobiotic metabolism. The human ortholog of mouse Cyp2c44 is not known. Human CYP2C8 and CYP2C9, thought to be the primary CYP2C epoxygenases, are both abundantly expressed in kidney and have a similar function (Enayetallah et al, 2004) . Studies with the human single nucleotide polymorphism (SNP) CYP2C8*3 have shown either a small but significant association with hypertension (Tzveova et al, 2015) or no association with hypertension (Dreisbach et al, 2005; King et al, 2005) . Further studies will be needed to clarify the association between polymorphisms such as CYP2C8*3 and hypertension in humans.
While the data in this manuscript provides a comprehensive profile of Cyp2c gene expression in mice, it does little to clarify the identity of the murine orthologs for the known human CYP2C genes. Humans have 4 CYP2C genes, CYP2C8, CYP2C9, CYP2C18 and CYP2C19 (Nelson et al, 2004) . Collectively, we find murine Cyp2c expression is restricted largely to the liver, gastrointestinal tract, and kidney. In humans,
CYP2C8 and CYP2C9 are expressed in all three of these tissues, but can also be found in other tissues, including heart, lung, lymph nodes, spleen, and skin (Enayetallah et al, 2004) . Metabolic studies with individual CYP2C proteins will be needed to clarify whether any of the murine CYP2Cs perform similar functions as the corresponding human CYP2C enzymes. Due to the complexity and high level of homology between the mouse Cyp2c subfamily members, it is exceedingly difficult to develop isoform specific antibodies. Future western blot analysis and immunohistochemistry studies will be essential to confirm the tissue distribution and sexual dimorphism for the mouse Cyp2c proteins. In addition, although human CYP2Cs also display sexually dimorphic expression, this occurs to a lesser degree than in mice. It is important to note these differences to fully understand and interpret drug metabolism data by CYP2Cs in humans compared to mice.
In summary, we developed SYBR Green primers, validated their specificity, and Cyp2c isoforms using both qPCR methods. Tissue expression profiles were also developed using our SYBR Green primer sets for the remaining four mouse Cyp2c isoforms that currently do not have paralog-specific TaqMan primer/probe assays.
Although primer/probe assays may offer increased specificity of target detection, the SYBR Green end-point melting curve dissociation analysis allows for verification that observed fluorescence is due to a single amplicon (or at least amplicons of similar melting temperature). Our developed mouse Cyp2c SYBR Green primer sets may be used as accurate and less expensive alternatives to the commercially available TaqMan primer/probe assays for the quantitative expression of the mouse Cyp2cs transcripts in tissues. In addition, our Cyp2c-specific SYBR Green primer sets may be used for the quantitative analysis in tissues where there is no specific TaqMan assay available. Relative tissue expression was normalized to Gapdh; ∆CT values (Cyp2c -Gapdh) are reported in the heat map (Fig. 2) . 
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